Market Overview

Why Axon Shares Got A Shock After The Q3 Print

Why Axon Shares Got A Shock After The Q3 Print
Jim Cramer Weighs In On Cisco, General Electric And More
Benzinga's Top Upgrades, Downgrades For November 9, 2018

Weapons technology company Axon Enterprise Inc. (NASDAQ: AAXN) reported a third-quarter earnings and sales beat Tuesday. Despite a surge in net income and a revenue increase of roughly 16 percent, the stock fell substantially following the report.

The Analyst

JPMorgan analyst Mark Strouse upgraded Axon from Neutral to Overweight and maintained a $68 price target. 

The Thesis

Axon’s reported guidance implies a dip in revenue growth in the fourth quarter, Strouse said in a Thursday note. (See his track record here.) 
The dip should be a temporary one, the analyst said. 

“The stock is now below the price of the May secondary offering, despite recent developments that we believe are long-term positives such as the launch of the TASER 7 and Axon Body 3, new officer safety payment plans with enhanced features and premium pricing, as well as being in closer proximity to the launch of Axon Records in mid-2019.”

Strouse expects that certain agencies will pause before deciding whether to buy older Tasers or the new TASER 7 in 2019. Contact announcements should demonstrate signs of progress and growth acceleration into 2019, he said. 

"We believe AAXN's uniquely strong position in a large addressable market, solid revenue growth momentum and improving EBITDA margins could provide upside to estimates over time." 

Price Action

Axon shares rose 4.95 percent to $53.21 during pre-market trading on Thursday. The stock had dipped over 15 percent following Wednesday’s close.

Related Links:

Analyst: The Bullish Case For Axon Isn't Based On Taser Sales Alone

Raymond James: Axon Still Underappreciated After 170% Pop

Photo courtesy of Axon. 

Latest Ratings for AAXN

Jan 2019Morgan StanleyMaintainsOverweightOverweight
Nov 2018BairdUpgradesNeutralOutperform
Nov 2018JP MorganUpgradesNeutralOverweight

View More Analyst Ratings for AAXN
View the Latest Analyst Ratings

Posted-In: earnings reportAnalyst Color Earnings News Guidance Upgrades Price Target Analyst Ratings Best of Benzinga


Related Articles (AAXN)

View Comments and Join the Discussion!

Mid-Morning Market Update: Markets Open Lower; Cardinal Health Tops Q1 Views

This Day In Market History: HBO Introduces Premium TV